Cardlytics Proceeds Revenue Contraction Amid Deteriorating Business Economics (NASDAQ: CDLX)

.Financial article writer recommends selling Cardlytics, Inc. as a result of dropping system economics, earnings challenges, as well as bad monetary trends. Click on for this CDLX update.